These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 24092851)

  • 1. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.
    Razonable RR; Hayden RT
    Clin Microbiol Rev; 2013 Oct; 26(4):703-27. PubMed ID: 24092851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of cytomegalovirus viral load in solid organ transplant recipients.
    Dioverti MV; Razonable RR
    Curr Opin Infect Dis; 2015 Aug; 28(4):317-22. PubMed ID: 26098497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cytomegalovirus infection and disease pre- and post-quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration?
    Dioverti MV; Lahr B; Razonable RR
    Clin Transplant; 2016 Feb; 30(2):154-60. PubMed ID: 26589482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
    Navarro D; San-Juan R; Manuel O; Giménez E; Fernández-Ruiz M; Hirsch HH; Grossi PA; Aguado JM;
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28859257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
    Razonable RR; Humar A
    Clin Transplant; 2019 Sep; 33(9):e13512. PubMed ID: 30817026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter comparison of laboratory performance in cytomegalovirus and Epstein-Barr virus viral load testing using international standards.
    Rychert J; Danziger-Isakov L; Yen-Lieberman B; Storch G; Buller R; Sweet SC; Mehta AK; Cheeseman JA; Heeger P; Rosenberg ES; Fishman JA
    Clin Transplant; 2014 Dec; 28(12):1416-23. PubMed ID: 25303316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients.
    Lisboa LF; Preiksaitis JK; Humar A; Kumar D
    Transplantation; 2011 Nov; 92(9):1063-8. PubMed ID: 21878838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of cytomegalovirus infection in organ transplant recipients.
    Kusne S; Shapiro R; Fung J
    Transpl Infect Dis; 1999 Sep; 1(3):187-203. PubMed ID: 11428989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients.
    Ramanan P; Razonable RR
    Expert Rev Mol Diagn; 2017 Jul; 17(7):633-639. PubMed ID: 28468570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Commercial methods for the diagnosis of CMV infection after organ or bone marrow transplantation].
    Schvoerer E; Stoll-Keller F
    Ann Biol Clin (Paris); 2002; 60(4):463-7. PubMed ID: 12147450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of cytomegalovirus: methodologic aspects and clinical applications.
    Boeckh M; Boivin G
    Clin Microbiol Rev; 1998 Jul; 11(3):533-54. PubMed ID: 9665982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N
    Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients.
    Razonable RR
    Infect Dis Clin North Am; 2013 Jun; 27(2):317-42. PubMed ID: 23714343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the AmpliSensor PCR and the SHARP signal detection system for the early prediction of symptomatic CMV infection in solid transplant recipients.
    Rautenberg P; Lübbert C; Weers W; Boetel E; Schweichler J; Zhou L; Costard-Jäckle A; Kraemer-Hansen H; Harder TC
    J Clin Virol; 1999 Jun; 13(1-2):81-94. PubMed ID: 10405895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistant Cytomegalovirus Infection in Solid-organ Transplantation: Single-center Experience, Literature Review of Risk Factors, and Proposed Preventive Strategies.
    Majeed A; Latif A; Kapoor V; Sohail A; Florita C; Georgescu A; Zangeneh T
    Transplant Proc; 2018 Dec; 50(10):3756-3762. PubMed ID: 30586840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.
    Emery VC; Sabin CA; Cope AV; Gor D; Hassan-Walker AF; Griffiths PD
    Lancet; 2000 Jun; 355(9220):2032-6. PubMed ID: 10885354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients.
    Cardeñoso L; Pinsky BA; Lautenschlager I; Aslam S; Cobb B; Vilchez RA; Hirsch HH
    J Clin Virol; 2013 Feb; 56(2):108-12. PubMed ID: 23146665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Utility of Cytomegalovirus Nucleic Acid Testing during Antigenemia-Guided Cytomegalovirus Monitoring after Hematopoietic Stem Cell Transplantation or Liver Transplantation.
    Morinaga Y; Sawayama Y; Hidaka M; Mori S; Taguchi J; Takatsuki M; Eguchi S; Miyazaki Y; Yanagihara K
    Tohoku J Exp Med; 2019 Mar; 247(3):179-187. PubMed ID: 30890664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.